Welcome to our dedicated page for Ecolab news (Ticker: ECL), a resource for investors and traders seeking the latest updates and insights on Ecolab stock.
Ecolab Inc. (NYSE: ECL) is a global sustainability-focused company that provides water, hygiene and infection prevention solutions and services for customers across food, healthcare, life sciences, hospitality, industrial and high tech markets. The ECL news page on Stock Titan aggregates company announcements, earnings updates and other material disclosures drawn from official news releases and SEC filings.
Investors and observers following Ecolab’s news can see how the company reports on its financial performance, including quarterly earnings releases furnished via Form 8‑K. These updates often include commentary on segment trends in Global Water, Global Institutional & Specialty, Global Pest Elimination and Global Life Sciences, as well as insights into growth engines such as Life Sciences, Pest Elimination, Global High-Tech and Ecolab Digital.
Ecolab’s news flow also highlights product launches and technology initiatives. Recent announcements describe integrated cooling programs for data centers, AI‑enhanced clean‑in‑place digital solutions for food and beverage producers, new sporicidal disinfectants for pharmaceutical cleanrooms and the expansion of the Ecolab® Scientific Clean™ product line through The Home Depot in Canada. These items show how the company applies science-based solutions and digital tools in water-intensive and hygiene-critical industries.
Another key theme in Ecolab’s news is sustainability and water stewardship. The company reports external recognition such as double ‘A’ ratings from CDP for water and climate, and publishes the Ecolab Watermark™ Study on global water issues and consumer expectations. For those tracking ECL, this news page offers a centralized view of corporate developments, strategic initiatives and environmental disclosures. Users can consult it regularly to review new releases and understand how Ecolab presents its strategy and operations over time.
Ecolab (ECL) reported strong Q2 2024 results with sales of $4.0 billion, up 3% year-over-year. Organic sales grew 4%, driven by a 7% increase in the Institutional & Specialty segment. Adjusted diluted EPS rose 35% to $1.68. The company increased its full-year 2024 adjusted EPS guidance to $6.50-$6.70, representing 25-29% growth.
Key highlights include:
- Operating income margin expanded 360 bps to 17.0% on an organic basis
- Free cash flow increased to $414 million
- Launched 'One Ecolab' initiative to drive growth and operational efficiencies
- Expects Q3 2024 adjusted EPS of $1.75-$1.85, up 14-20% year-over-year
Ecolab continues to outperform soft macroeconomic trends through market share gains, innovation, and operational improvements.
Ecolab will host a live webcast to discuss its Q2 2024 earnings on July 30, 2024. The webcast will begin at 1:00 p.m. Eastern Time and last for one hour. A news release containing the Q2 results will be issued before the market opens on the same day. The webcast can be accessed at www.ecolab.com/investor, and a replay along with supplemental data will be available on the site.
Ecolab, in partnership with Repligen , announced the commercial launch of DurA Cycle Affinity Resin, designed for large-scale purification in biologic manufacturing. This product, launched at BIO 2024 in San Diego, targets efficient monoclonal antibody production, reducing costs for biologic drug developers. The launch reflects Ecolab's ongoing commitment to bioprocessing innovations, following two other resins launched in the past eighteen months. The partnership aims to address complex challenges in biologic manufacturing and is bolstered by Ecolab's investment in a new production facility in Landenberg, PA, complementing its UK-based facility.
Ecolab will webcast a presentation by its Chairman and CEO, Christophe Beck, at the William Blair Growth Stock Conference on June 4, 2024. The event will start at 11:40 a.m. Eastern Time and will last for about 30 minutes. This webcast will be accessible via Ecolab's investor website, with a replay available until June 28, 2024.
Ecolab has released its 2023 Growth & Impact Report, highlighting its economic, environmental, social, and governance achievements. The report details significant progress toward Ecolab's 2030 Positive Impact goals. Key milestones in 2023 include conserving 226 billion gallons of water, providing safe food to 1.4 billion people, and avoiding 3.8 million metric tons of greenhouse gas emissions. Ecolab also reached 100% renewable electricity in its European operations and advanced its electric vehicle conversion efforts in North America. Additional achievements include AWS certifications in Monterrey and Nanjing, donating $18.5 million to global communities, and launching the California Water Resilience Initiative. These accomplishments underscore Ecolab's mission to integrate science-based solutions, enhance business health, and drive sustainability.
Ecolab and HeiQ Chrisal collaborate to launch Maxx Synbiotic cleaning products at Interclean in Amsterdam, introducing advanced synbiotic cleaning technology to the European market. The products deliver immediate, microscopic-level cleaning, efficient odor reduction, and support for a well-balanced microbiome on surfaces. HeiQ's technology has been validated in scientific studies, offering a promising future for the cleaning industry.
Ecolab Inc. announced the election of twelve director nominees for a one-year term, approval of executive officers' compensation, and ratification of an accounting firm at its annual meeting. A stockholder proposal on an independent board chair policy was not approved. The final vote tabulation will be reported to the SEC.
Ecolab Inc. announced a regular quarterly cash dividend of $0.57 per common share, to be paid on July 15, 2024, to shareholders of record on June 18, 2024. This marks the 87th consecutive year of cash dividends being paid on Ecolab's common stock.
Ecolab Inc. reported very strong first-quarter performance with diluted EPS at $1.43 and adjusted diluted EPS at $1.34, a 52% increase. Sales grew by 5%, organic sales by 5%, and operating income margin by 13.8% to 14.7%. Ecolab has agreed to sell its global surgical solutions business for $950 million. The outlook for 2024 includes an adjusted diluted EPS range of $6.40 - $6.70, a 23% - 29% increase.
Summary not available.